课题基金 / 基金详情

Plasmonic PCR: Rapid Point-of-Care COVID-19 Diagnostic Platform.

Plasmonic PCR: Rapid Point-of-Care COVID-19 Diagnostic Platform.
等离子 PCR：快速护理点 COVID-19 诊断平台。
批准号：
422581
负责人：
Trifiro Mark A
金额：
$52.28万
依托单位：
Lady Davis Institute for Medical Research (Mtl)
依托单位国家：
加拿大
项目类别：
Operating Grants
财政年份：
2020
资助国家：
加拿大
项目状态：
已结题
起止时间：
2020-02-01 至 2022-02-01
来源：
https://webapps.cihr-irsc.gc.ca/decisions/p/project_details.html?applId=422581&lang=en
关键词：
Covid-19 Plasmonic Pcr Point-Of-Care Device Rt-Qpcr

项目摘要

项目成果

Trifiro Mark A的其他基金

相似基金

相关文献

中文摘要
翻译
点击翻译按钮获取中文摘要
英文摘要
The recent outbreak of the coronavirus COVID-19 pandemic clearly demonstrates how in today's age infectious agents can spread rapidly. Given the ability of individuals to travel across the globe infectious agents can reach pandemic/epidemic proportions qu
期刊论文(0)
专著(0)
科研奖励(0)
会议论文
Using a novel androgen receptor knock-in mouse model to investigate defects in circadian rhythm linked to the development Metabolic Syndrome.
Ultra-fast High Throughput Digital PCR Platform: Redefining Point-of-Care Diagnostics
Targeting novel BioNanofluids for prostate cancer therapy
Innovative Approaches to Functional Characterization of the Androgen Receptor in Prostate Cancer
海外基金